“Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s726. https://doi.org/10.25251/mjfdzc48.